Company has spent less than 1% of its operating revenues towards interest expenses and 22.71% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Genomic Valley Biotech Share Price
Genomic Valley Biotech ...
Genomic Valley Biotech share price insights
Genomic Valley Biotech Ltd. share price moved up by 1.84% from its previous close of Rs 65.00. Genomic Valley Biotech Ltd. stock last traded price is 66.20
Share Price Value Today/Current/Last 66.20 Previous Day 65.00
Key Metrics
PE Ratio (x) | 158.01 | ||||||||||
EPS - TTM (₹) | 0.42 | ||||||||||
MCap (₹ Cr.) | 20.22 | ||||||||||
Sectoral MCap Rank | 192 | ||||||||||
PB Ratio (x) | 5.60 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 65.96 | ||||||||||
52W H/L (₹) |
Genomic Valley Biotech Share Price Returns
1 Day | 1.84% |
1 Week | 5.92% |
1 Month | 24.91% |
3 Months | 71.28% |
1 Year | 194.22% |
3 Years | N.A. |
5 Years | N.A. |
Genomic Valley Biotech News & Analysis
Genomic Valley Biotech Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Genomic Valley Biotech Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 22.71% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 0.16 0.00 0.04 0.07 0.06 Total Income Growth (%) - -100.00 -42.24 12.44 -94.04 Total Expenses 0.03 0.04 0.02 0.04 0.03 Total Expenses Growth (%) -37.89 158.70 -61.09 33.30 19.01 EBIT 0.13 -0.04 0.02 0.02 0.03 EBIT Growth (%) - -304.96 -6.25 -13.43 -97.26 Profit after Tax (PAT) 0.13 -0.04 0.02 0.02 0.03 PAT Growth (%) - -304.96 -6.25 -13.43 -97.26 EBIT Margin (%) 82.16 - 55.79 34.38 44.65 Net Profit Margin (%) 82.16 - 55.79 34.38 44.65 Basic EPS (₹) 0.42 -0.15 0.07 0.08 0.09 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 4.33 4.42 3.80 7.62 8.01 Total Assets Growth (%) -2.04 16.32 -50.13 -4.87 11.56 Total Liabilities 0.79 0.89 0.92 3.13 2.96 Total Liabilities Growth (%) -11.24 -3.26 -70.61 5.74 22.31 Total Equity 3.54 3.53 2.88 4.49 5.05 Total Equity Growth (%) 0.28 22.57 -35.86 -11.09 6.09 Current Ratio (x) 3.68 2.89 5.31 0.19 0.53 Total Debt to Equity (x) 0.00 0.17 0.00 0.34 0.29 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities -0.02 -0.78 -2.13 1.48 0.44 Net Cash used in Investing Activities -0.02 1.52 3.67 -1.58 -0.47 Net Cash flow from Financing Activities - -0.70 -1.55 0.07 - Net Cash Flow -0.04 0.04 -0.01 -0.03 -0.04 Closing Cash & Cash Equivalent 0.00 0.04 0.00 0.01 0.04 Closing Cash & Cash Equivalent Growth (%) -94.46 1,441.91 -76.61 -69.66 -49.70 Total Debt/ CFO (x) 0.00 -0.78 0.00 1.04 3.38 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 0.42 18.38 -0.32 -12.45 5.66 Return on Capital Employed (%) 0.42 25.89 -10.55 -4.80 5.32 Return on Assets (%) 0.35 14.66 -0.24 -7.33 3.57 Interest Coverage Ratio (x) 0.00 0.00 -6.89 -1.83 2.14 Asset Turnover Ratio (x) 0.04 0.66 0.01 2.73 10.57 Price to Earnings (x) 714.29 10.26 -833.33 -12.90 9.26 Price to Book (x) 2.99 1.88 2.63 1.61 0.52 EV/EBITDA (x) 650.07 7.83 -25.72 -64.70 7.24 EBITDA Margin (%) 9.87 33.83 -416.43 -64.94 66.64
Genomic Valley Biotech Peer Comparison
Genomic Valley Biotech Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Genomic Valley Biotech Board Meeting/AGM
Genomic Valley Biotech Dividends
- Others
Meeting Date Announced on Purpose Details Jul 29, 2024 Jul 23, 2024 Board Meeting Quarterly Results May 09, 2024 May 03, 2024 Board Meeting Audited Results Feb 14, 2024 Feb 10, 2024 Board Meeting Quarterly Results Feb 10, 2024 Feb 10, 2024 Board Meeting Quarterly Results Nov 14, 2023 Nov 08, 2023 Board Meeting Quarterly Results Dividend announcements are not available.
No other corporate actions details are available.
About Genomic Valley Biotech
Genomic Valley Biotech Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 19.85 Crore) operating in Miscellaneous sector. Genomic Valley Biotech Ltd. key Products/Revenue Segments include Cut Flowers for the year ending 31-Mar-2023. Show More
Executives
Auditors
- YA
Yogesh Agrawal
Managing DirectorPAParul Agrawal
Non Executive DirectorJBJyoti Bansal
Ind. Non-Executive DirectorPKPraveen Kumar Mishara
Ind. Non-Executive DirectorShow More - Andros & CoA K Khattar & Associates
Industry
Key Indices Listed on
-
Address
4KM Stone,Berry Charra Road,Jhajjar District, Haryana - 124507
More Details
Trending in Markets
Genomic Valley Biotech Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.